Zymeworks ZYME
NASDAQ ZYME
$27.98 +1.07 (+3.98%)
As of: Oct 21, 2026 · 1:38 PM EDT

Zymeworks (ZYME) Shares Repurchased (2024 - 2026)

Updated

Analysis

Zymeworks (ZYME) Shares Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn 221.00 Mn
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn 9.00 Mn
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn -
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn -
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn 355.00 Mn
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn -
10 Zymeworks 2.04 Bn 926.93 Mn - 51.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.95 Mn
Mar 31, 2026 76.15 Mn
Dec 31, 2025 25.48 Mn
Sep 30, 2025 16.22 Mn
Dec 31, 2024 9.43 Mn
API Access

Zymeworks Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=ZYME&period=max&api_key=YOUR_API_KEY